Influx Healthtech (NSE:INFLUX) FCF Margin %: -12.77% (As of Mar. 2026)


NSE:INFLUX Influx Healthtech Ltd NSE:INFLUX
21 GF Score
Price ₹301.10
! 4 Warning Signs
View Full Analysis

What is Influx Healthtech FCF Margin %?

Influx Healthtech NSE:INFLUX +2.90% 21 FCF Margin % is -12.77% as of Mar. 2026. GuruFocus rates NSE:INFLUX with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 960 Drug Manufacturers companies, Influx Healthtech ranks worse than 77.6% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Influx Healthtech's Free Cash Flow for the six months ended in Mar. 2026 was ₹-102 Mil. Influx Healthtech's Revenue for the six months ended in Mar. 2026 was ₹801 Mil. Therefore, Influx Healthtech's FCF Margin % for the quarter that ended in Mar. 2026 was -12.77%.

As of today, Influx Healthtech's current FCF Yield % is -2.96%.

The historical rank and industry rank for Influx Healthtech's FCF Margin % or its related term are showing as below:

NSE:INFLUX' s FCF Margin % Range Over the Past 10 Years
Min: -14.08   Med: 0.08   Max: 2.59
Current: -14.08

During the past 5 years, the highest FCF Margin % of Influx Healthtech was 2.59%. The lowest was -14.08%. And the median was 0.08%.

NSE:INFLUX's FCF Margin % is ranked worse than
77.6% of 960 companies
in the Drug Manufacturers industry
Industry Median: 2.48 vs NSE:INFLUX: -14.08

Influx Healthtech FCF Margin % Related Terms

Influx Healthtech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Influx Healthtech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Influx Healthtech FCF Margin % Chart

Influx Healthtech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
0.08 2.59 0.59 -1.11 -14.08

Influx Healthtech Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 -15.65 -12.77

NSE:INFLUX vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Influx Healthtech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Influx Healthtech FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Influx Healthtech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Influx Healthtech's FCF Margin % falls into.


NSE:INFLUX
21GF Score
Influx Healthtech Ltd NSE:INFLUX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Influx Healthtech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Influx Healthtech's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-206.754/1468.336
=-14.08 %

Influx Healthtech's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-102.242/800.69
=-12.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -12.77% mean?
Influx Healthtech (NSE:INFLUX) has a FCF Margin % of -12.77% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Influx Healthtech and its competitors. According to the industry distribution chart, Influx Healthtech ranks #745 out of 960 companies in the Drug Manufacturers industry, placing it in the top 77.6%.
Is Influx Healthtech's FCF Margin % too high?
Influx Healthtech's current FCF Margin % is -12.77%. Based on the distribution chart, Influx Healthtech ranks #745 out of 960 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Influx Healthtech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Influx Healthtech ranks #745 out of 960 companies for FCF Margin %. This places Influx Healthtech in the lower half of its industry. The industry median FCF Margin % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Influx Healthtech and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Influx Healthtech's current FCF Margin % is -12.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current FCF Margin % of -12.77%. The current FCF Margin % is -12.77%. Influx Healthtech's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current FCF Margin % is -12.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Influx Healthtech Business Description

Address Plot No. 856, 109, Ghanshyam Enclave Premises Co-op Society, Behind Laljipada Police Chowky, Kandivali West, Mumbai, MH, IND, 400067
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
21GF Score

Get the complete analysis for NSE:INFLUX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹301.10
Price